Fresh From the Bench: Latest Precedential Patent Case
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Beteiro, LLC v. Draftkings Inc., Appeal Nos. 2022-2275, -2277, -2278, -2279, -2281, 2283 (Fed. Cir. June 21, 2024)
In its only precedential patent opinion this week, the Federal Circuit affirmed the Rule 12(b)(6) dismissal of multiple infringement cases brought by appellant Beteiro on grounds that its remote gambling patents were directed to patent-ineligible subject matter under 35 U.S.C. § 101. The Court’s opinion collected authority on “several features that are well-settled indicators of abstractness,” and rejected Beteiro’s attempts at “creative pleading” to raise a fact dispute as to patent eligibility.
Beteiro asserted four patents against multiple online gaming companies, with claims generally directed to the use of computers and GPS devices to determine whether a remote gambler’s bet is placed from a jurisdiction where such activity is lawful. At step one of the Alice/Mayo test for patent eligibility, the Federal Circuit readily agreed with the district court that the claims were “directed to the abstract idea of ‘exchanging information concerning a bet and allowing or disallowing the bet based on where the user is located.’”
Editors:
Nika Aldrich, IP Litigation Group Leader, Schwabe, Williamson & Wyatt
Jason A. Wrubleski, Shareholder
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…